FEROX STRATEGIES

Lobbying for ELI LILLY AND COMPANY · American pharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 17, 2025

Lobbying activity 1

Pharmacy

Issues related to the pharmaceutical industry. Issues related to Treating and Reducing Obesity.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.